The μ1 72-96 loop controls conformational transitions during reovirus cell entry

Journal of Virology

Volumn 87, Issue 24, 2013, Pages 13532-13542

  Sarkar, Payel ^a   Danthi, Pranav ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENETIC ENGINEERING; MOLECULAR STABILITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REOVIRUS; REOVIRUS INFECTION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PARTICLE; VIRUS TRANSFORMATION; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; CAPSID; CAPSID PROTEINS; CELL LINE; CRYSTALLIZATION; MAMMALIAN ORTHOREOVIRUS 3; MICE; MUTATION; PROTEIN CONFORMATION; REOVIRIDAE; REOVIRIDAE INFECTIONS; VIRUS INTERNALIZATION;

EID: 84888020607     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01899-13     Document Type: Article

References (50)

1. Dermody TS, Parker JC, Sherry B. 2013. Orthoreoviruses. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Drayna D, Fields BN. 1982. Genetic studies on the mechanism of chemical and physical inactivation of reovirus. J. Gen. Virol. 63:149-160.
3. Middleton JK, Agosto MA, Severson TF, Yin J, Nibert ML. 2007. Thermostabilizing mutations in reovirus outer-capsid protein σ1 selected by heat inactivation of infectious subvirion particles. Virology 361:412-425.
4. Middleton JK, Severson TF, Chandran K, Gillian AL, Yin J, Nibert ML. 2002. Thermostability of reovirus disassembly intermediates (ISVPs) correlates with genetic, biochemical, and thermodynamic properties of major surface protein mu1. J. Virol. 76:1051-1061.
5. Hooper JW, Fields BN. 1996. Role of the μ1 protein in reovirus stability and capacity to cause chromium release from host cells. J. Virol. 70:459-467.
6. Wessner DR, Fields BN. 1993. Isolation and genetic characterization of ethanol-resistant reovirus mutants. J. Virol. 67:2442-2447.
7. Danthi P, Kobayashi T, Holm GH, Hansberger MW, Abel TW, Dermody TS. 2008. Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency. J. Virol. 82:161-172.
8. Drayna D, Fields BN. 1982. Activation and characterization of the reovirus transcriptase:genetic analysis. J. Virol. 41:110-118.
9. Madren JA, Sarkar P, Danthi P. 2012. Cell entry-associated conformational changes in reovirus particles are controlled by host protease activity. J. Virol. 86:3466-3473.
10. Liemann S, Chandran K, Baker TS, Nibert ML, Harrison SC. 2002. Structure of the reovirus membrane-penetration protein, μ1, in a complex with its protector protein, σ3. Cell 108:283-295.
11. Zhang X, Ji Y, Zhang L, Harrison SC, Marinescu DC, Nibert ML, Baker TS. 2005. Features of reovirus outer capsid proteinμ1 revealed by electron cryomicroscopy and image reconstruction of the virion at 7.0 Å resolution. Structure 13:1545-1557.
12. Dryden KA, Wang G, Yeager M, Nibert ML, Coombs KM, Furlong DB, Fields BN, Baker TS. 1993. Early steps in reovirus infection are associated with dramatic changes in supramolecular structure and protein conformation:analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction. J. Cell Biol. 122:1023-1041.
13. Danthi P, Guglielmi KM, Kirchner E, Mainou B, Stehle T, Dermody TS. 2010. From touchdown to transcription:the reovirus cell entry pathway. Curr. Top. Microbiol. Immunol. 343:91-119.
14. Boulant S, Stanifer M, Kural C, Cureton DK, Massol R, Nibert ML, Kirchhausen T. 2013. Similar uptake but different trafficking and escape routes of reovirus virions and ISVPs imaged in polarized MDCK cells. Mol. Biol. Cell. 24:1196-1207.
15. Maginnis MS, Mainou BA, Derdowski A, Johnson EM, Zent R, Dermody TS. 2008. NPXY motifs in the beta1 integrin cytoplasmic tail are required for functional reovirus entry. J. Virol. 82:3181-3191.
16. Mainou BA, Dermody TS. 2011. Src kinase mediates productive endocytic sorting of reovirus during cell entry. J. Virol. 85:3203-3213.
17. Mainou BA, Dermody TS. 2012. Transport to late endosomes is required for efficient reovirus infection. J. Virol. 86:8346-8358.
18. Mainou BA, Zamora PF, Ashbrook AW, Dorset DC, Kim KS, Dermody TS. 2013. Reovirus cell entry requires functional microtubules. mBio 4:e00405-13. doi:10.1128/mBio.00405-13.
19. Maginnis MS, Forrest JC, Kopecky-Bromberg SA, Dickeson SK, Santoro SA, Zutter MM, Nemerow GR, Bergelson JM, Dermody TS. 2006. Beta1 integrin mediates internalization of mammalian reovirus. J. Virol. 80:2760-2770.
20. Schulz WL, Haj AK, Schiff LA. 2012. Reovirus uses multiple endocytic pathways for cell entry. J. Virol. 86:12665-12675.
21. Borsa J, Copps TP, Sargent MD, Long DG, Chapman JD. 1973. New intermediate subviral particles in the in vitro uncoating of reovirus virions by chymotrypsin. J. Virol. 11:552-564.
22. Chang CT, Zweerink HJ. 1971. Fate of parental reovirus in infected cell. Virology 46:544-555.
23. Baer GS, Ebert DH, Chung CJ, Erickson AH, Dermody TS. 1999. Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly. J. Virol. 73:9532-9543.
24. Silverstein SC, Astell C, Levin DH, Schonberg M, Acs G. 1972. The mechanism of reovirus uncoating and gene activation in vivo. Virology 47:797-806.
25. Ebert DH, Deussing J, Peters C, Dermody TS. 2002. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J. Biol. Chem. 277:24609-24617.
26. Sturzenbecker LJ, Nibert ML, Furlong DB, Fields BN. 1987. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J. Virol. 61:2351-2361.
27. Amerongen HM, Wilson GAR, Fields BN, Neutra MR. 1994. Proteolytic processing of reovirus is required for adherence to intestinal M cells. J. Virol. 68:8428-8432.
28. Bass DM, Bodkin D, Dambrauskas R, Trier JS, Fields BN, Wolf JL. 1990. Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice. J. Virol. 64:1830-1833.
29. Bodkin DK, Nibert ML, Fields BN. 1989. Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice. J. Virol. 63:4676-4681.
30. Nygaard RM, Golden JW, Schiff LA. 2012. Impact of host proteases on reovirus infection in the respiratory tract. J. Virol. 86:1238-1243.
31. Chandran K, Farsetta DL, Nibert ML. 2002. Strategy for nonenveloped virus entry:a hydrophobic conformer of the reovirus membrane penetration protein μ1 mediates membrane disruption. J. Virol. 76:9920-9933.
32. Chandran K, Parker JS, Ehrlich M, Kirchhausen T, Nibert ML. 2003. The delta region of outer-capsid protein μ1 undergoes conformational change and release from reovirus particles during cell entry. J. Virol. 77:13361-13375.
33. Sarkar P, Danthi P. 2010. Determinants of strain-specific differences in efficiency of reovirus entry. J. Virol. 84:12723-12732.
34. Nibert ML, Odegard AL, Agosto MA, Chandran K, Schiff LA. 2005. Putative autocleavage of reovirus μ1 protein in concert with outer-capsid disassembly and activation for membrane permeabilization. J. Mol. Biol. 345:461-474.
35. Zhang L, Chandran K, Nibert ML, Harrison SC. 2006. Reovirus σ1 structural rearrangements that mediate membrane penetration. J. Virol. 80:12367-12376.
36. Agosto MA, Ivanovic T, Nibert ML. 2006. Mammalian reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane. Proc. Natl. Acad. Sci. U.S.A. 103:16496-16501.
37. Ivanovic T, Agosto MA, Zhang L, Chandran K, Harrison SC, Nibert ML. 2008. Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. EMBO J. 27:1289-1298.
38. Zhang L, Agosto MA, Ivanovic T, King DS, Nibert ML, Harrison SC. 2009. Requirements for the formation of membrane pores by the reovirus myristoylated micro1N peptide. J. Virol. 83:7004-7014.
39. Kobayashi T, Antar AA, Boehme KW, Danthi P, Eby EA, Guglielmi KM, Holm GH, Johnson EM, Maginnis MS, Naik S, Skelton WB, Wetzel JD, Wilson GJ, Chappell JD, Dermody TS. 2007. A plasmidbased reverse genetics system for animal double-stranded RNA viruses. Cell Host Microbe 1:147-157.
40. Kobayashi T, Ooms LS, Ikizler M, Chappell JD, Dermody TS. 2010. An improved reverse genetics system for mammalian orthoreoviruses. Virology 398:194-200.
41. Berard A, Coombs KM. 2009. Mammalian reoviruses:propagation, quantification, and storage. Curr. Protoc. Microbiol. Chapter 15:Unit15C.11.
42. Smith RE, Zweerink HJ, Joklik WK. 1969. Polypeptide components of virions, top component and cores of reovirus type 3. Virology 39:791-810.
43. Nibert ML, Chappell JD, Dermody TS. 1995. Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved σ1 protein. J. Virol. 69:5057-5067.
44. Wetzel JD, Wilson GJ, Baer GS, Dunnigan LR, Wright JP, Tang DS, Dermody TS. 1997. Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly. J. Virol. 71:1362-1369.
45. Reinisch KM, Nibert ML, Harrison SC. 2000. Structure of the reovirus core at 3.6 Å resolution. Nature 404:960-967.
46. Agosto MA, Middleton JK, Freimont EC, Yin J, Nibert ML. 2007. Thermolabilizing pseudoreversions in reovirus outer-capsid protein micro 1 rescue the entry defect conferred by a thermostabilizing mutation. J. Virol. 81:7400-7409.
47. Zhang X, Jin L, Fang Q, Hui WH, Zhou ZH. 2010. 3.3 A cryo-EM structure of a nonenveloped virus reveals a priming mechanism for cell entry. Cell 141:472-482.
48. Zhang X, Tang J, Walker SB, O'Hara D, Nibert ML, Duncan R, Baker TS. 2005. Structure of avian orthoreovirus virion by electron cryomicroscopy and image reconstruction. Virology 343:25-35.
49. Danthi P, Coffey CM, Parker JS, Abel TW, Dermody TS. 2008. Independent regulation of reovirus membrane penetration and apoptosis by the mu1 phi domain. PLoS Pathog. 4:e1000248.
50. Rubin DH, Fields BN. 1980. Molecular basis of reovirus virulence:role of the M2 gene. J. Exp. Med. 152:853-868.